Skip to main content
SEBI Registered Research Analyst — INH000009269

Your Financial
Doctor for Confident
Investing

We study the market so you don't have to. Clear research, honest views, and a process you can trust — from a SEBI-registered team that puts your clarity first.

5 free reports on signup — analyze any NSE stock or index

NIFTY—
BANKNIFTY—
SENSEX—
SEBI Regulated
LIVE

This is how a recommendation is bornIllustrative · fictional names

ABC+0.8%
BCD+1.9%
CDE−0.6%
DEF−1.4%
EFG+0.3%
FGH−0.9%
GHI+2.4%
HIJ+1.1%
IJK+1.6%
JKL−2.1%
KLM+0.4%
LMN−0.3%
MNO+2.9%
NOP−1.2%
OPQ+0.7%
PQR−1.8%
QRS+1.4%
RST+0.2%
STU+2.2%
TUV−0.5%
UVW−2.6%
VWX+0.9%
WXY−0.7%
XYZ+3.1%
YZA+0.1%
Technical
Fundamental
Sentiment
strategy / trend-continuationv1
IF
AND55–7058–68
AND1.5×1.8× 20-day avg
THEN
Back-testHistorical data
Market cyclesDrawdownsOut-of-sample
GHI Ltd
T
F
S
MNO Ltd
T
F
S
STU Ltd
T
F
S
XYZ Ltd
T
F
S
TRADE ENCORE
Research report · PositionalSample
XYZ Ltd
Technical
Fundamental
Sentiment
Entry
₹ • • •
Target
₹ • • •
Stop-loss
₹ • • •
Rationale
Risk factors
SEBI Reg. No. INH000009269 · Disclosures included
Live market · prices moving

Seven steps — keep scrolling to watch it happen.

  1. 01Strategy written & back-tested
  2. 02Every stock scored, alerts fire
  3. 03The research desk checks every alert
  4. 04Three analyses for each survivor
  5. 05Filtered to the strongest
  6. 06A recommendation is born
  7. 07Delivered to your phone

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

The visual above is an illustration of our process — the names are fictional and it shows no real company, price, return or recommendation.

Now try it on a real stock

Every stock, scored every night.

The same three pillars you just watched — technical, fundamental, sentiment — computed every night for every stock we cover. Looking one up is free.

Trade Encore — SEBI Registered Research Analyst · Reg. No. INH000009269 · BSE Enlistment 5530

Registered office: Cabin No. 20, Runwal Platinum, The Office Club, Bavdhan, Pune — 411021

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Past performance is not indicative of future results.

Non-personalised research: This comparison is non-personalised research. It is identical for every user and is not based on your holdings, financial situation, risk profile, or investment objectives. It is not investment advice tailored to you. Consider your own circumstances, and consult a SEBI-registered investment adviser, before acting.

AI use: Scores and the reasons shown here are produced by a deterministic, rules-based nightly computation using technical and fundamental data — no AI/LLM is used to generate them. Where an optional paid 'deep research note' is requested, that single feature uses AI; such notes are clearly labelled and are assistive commentary, not advice.

What discount broking did for trading, we do for research.

Professional, SEBI-registered research at a reasonable cost. Commission-free: we don't sell products, we sell research.

“Trade Encore's research-backed approach has transformed how I invest. Their disciplined methodology and transparent track record give me confidence in every recommendation.”
Verified MemberActive Subscriber since 2023

Investor CharterGrievance RedressalTerms & DisclosuresPrivacyCompliance Centre

Just got your first salary? Start here.

Fin Silver, ₹149/month — mutual fund and long-term equity ideas, with entry, target and stop-loss spelled out on every one.

In plain words

What Trade Encore is, in plain words

Trade Encore is a SEBI Registered Research Analyst firm based in Pune (Reg. No. INH000009269, BSE Enlistment 5530). We publish research-backed recommendations on Indian equities, mutual funds and derivatives — every idea with a defined entry zone, a stop-loss and targets — and we charge for the research itself rather than earning commission on products.

What we publish

Long-term equity and positional recommendations, mutual fund research scored category-relative from official AMFI NAVs, F&O strategies for experienced traders, independent IPO evaluations, and a daily pre-market outlook. Members receive every recommendation on their dashboard, by email and by push notification, with the reasoning attached — not a bare tip.

How the research is made

Stock and fund scores are computed nightly by a deterministic, rules-based batch — technical trend and momentum, ten fundamental ratios normalised against the stock's own sector, and a bounded sentiment reading. No language model produces a score, and a pillar with no fresh data is excluded and the score flagged provisional rather than quietly filled in. Every score carries the date it was computed.

What it costs

A single stock report is a one-off purchase with no subscription; a private 30-minute call can be booked on its own; and memberships are priced by how you invest rather than by a credit quota, starting from ₹149 a month. The pricing page is authoritative and always current.

How we are regulated

As a SEBI Registered Research Analyst we publish non-personalised research: it is identical for every reader and is never based on your holdings, income or risk profile, so it is not investment advice tailored to you. Registration does not guarantee performance or assure returns. Our disclosures, investor charter and grievance redressal route are public.

Read more: Products · Pricing · How research works · How we are paid · Compliance Centre · FAQ

SEBI Registration No.: INH000009269 | BSE Enlistment No.: 5530 — Investment in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.